By Puyaan Singh Jan 12 (Reuters) - Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday ...
Gilead stock toppled Thursday after CVS HealthCVS said it won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now. The decision is based on clinical, financial and ...
Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. A twice-yearly injection of a drug known as lenacapavir offered ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results